,Element Name,Element Type,Element ID,Location,Location ID,Cell Line,Cell Type,Organism,Positive Reg Name,Positive Reg Type,Positive Reg ID,Positive Reg Location,Positive Reg Location ID,Negative Reg Name,Negative Reg Type,Negative Reg ID,Negative Reg Location,Negative Reg Location ID,Connection Type,Database Name,Mechanism,Paper ID,Evidence,Evidence Score,Match Score,Kind Score,Epistemic Value,Total Score
76,erk,bioprocess,d020928,nan,nan,nan,nan,nan,ras,family,pf00071,nan,nan,nan,nan,nan,nan,nan,i,"['nan', 'nan', 'nan', 'nan']","['activation', 'activation', 'activation', 'inhibition']","['pmc2064279', 'pmc4254013', 'pmc4440819', 'pmc4440819']","['oncogenic ras causes constitutive activation of the erk pathway, resulting in cellular transformation and tumorigenesis.', 'further investigation of individual contribution of the ras isoforms indicated kras as major ras activator of the erk signaling in these cells.', 'the ras induced erk pathway (raf -- mek -- erk) is typically activated by growth factors through their receptor tyrosine kinases (rtks), which mobilize adaptor proteins, such as shc and grb2, and guanine nucleotide exchange factors (gefs) like sos.', 'da-raf binds to active ras and suppresses the erk pathway.']",4,100.0,40.0,1.0,440.0
174,raf,nan,nan,nan,nan,nan,nan,nan,ras,family,pf00071,nan,nan,nan,nan,nan,nan,nan,i,"['nan', 'nan']","['activation', 'activation']","['pmc2064279', 'pmc4067595']","['ras activates raf, leading to the extracellular regulated kinase (erk)-mitogen-activated protein kinase pathway, which is involved in a variety of cellular, physiological, and pathological responses.', 'all four isoforms of ras are able to activate all three members of the raf gene family (a raf, b raf, raf-1).']",2,100.0,40.0,1.0,240.0
65,erk,bioprocess,d020928,nan,nan,nan,nan,nan,fgf1,protein,p05230,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4440819'],"['furthermore, these conclusions are in line with the previous findings that the ras -- erk pathway induced by hepatocyte growth factor (hgf) or fgf1 interferes with tgf-beta1-induced emt in primary cultured aecs and aec cell lines [xref_bibr, xref_bib']",1,100.0,40.0,1.0,140.0
80,erk,bioprocess,d020928,nan,nan,nan,nan,nan,tgfb1,protein,p01137,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4440819'],"['thus, regulatory mechanisms of the weak and transient activation of the ras -- erk pathway induced by tgf-beta1 need to be elucidated.']",1,100.0,40.0,1.0,140.0
173,raf,nan,nan,nan,nan,nan,nan,nan,ksr,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4020307'],"['the scaffold protein ksr (kinase suppressor of ras) helps in raf activation, but also contributes to the sequential phosphorylation steps of the mapk cascade by bringing together mapk components, raf, mek and erk and mapk.']",1,100.0,40.0,1.0,140.0
67,erk,bioprocess,d020928,nan,nan,nan,nan,nan,fos_family,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc2911390'],"['these include multiple transcription factors and targets of erk signaling such as fos and ier3 as well as mapk-phosphatases and sprouty genes involved in feedback inhibition of mek and erk signaling (dual specificity phosphatases 6 (dusp6), dusp1, du']",1,100.0,40.0,1.0,140.0
71,erk,bioprocess,d020928,nan,nan,nan,nan,nan,ndpks,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc4020307'],"['thus, ndpks might attenuate ras and erk signaling through phosphorylation (thus inactivation) of ksr scaffolds.']",1,100.0,40.0,1.0,140.0
72,erk,bioprocess,d020928,nan,nan,nan,nan,nan,nme1,protein,p15531,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc4020307'],"['in this review i summarize how nm23-h1 inhibits the ras and erk cascade in human cell lines, and examine how the nm23 homolog ndk-1 modifies the outcome of ras signaling in the model organism caenorhabditis elegans [xref_bibr].']",1,100.0,40.0,1.0,140.0
73,erk,bioprocess,d020928,nan,nan,nan,nan,nan,nme2,protein,p22392,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc4020307'],['it was also suggested that increased levels of nm23-h2 block the erk pathway [xref_bibr].'],1,100.0,40.0,1.0,140.0
74,erk,bioprocess,d020928,nan,nan,nan,nan,nan,pebp1,protein,p30086,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc2064279'],['both spry and rkip bind to raf to inhibit the erk pathway by preventing the binding of mek.'],1,100.0,40.0,1.0,140.0
66,erk,bioprocess,d020928,nan,nan,nan,nan,nan,fgf2,protein,p09038,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4440819'],"['in contrast, fgf2 stimulation or overexpression of constitutively active ras, raf, or mek enhances the activity of the tgf-beta1-induced ras -- erk pathway.']",1,100.0,40.0,1.0,140.0
77,erk,bioprocess,d020928,nan,nan,nan,nan,nan,smad2_3,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['phosphorylation'],['pmc4440819'],['nan'],1,100.0,40.0,1.0,140.0
78,erk,bioprocess,d020928,nan,nan,nan,nan,nan,tgf- beta,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4440819'],"['tgf- beta also induces both the ras -- erk pathway and pi3k -- akt signaling as non smad signaling [xref_bibr, xref_bibr].']",1,100.0,40.0,1.0,140.0
79,erk,bioprocess,d020928,nan,nan,nan,nan,nan,tgfb,bioprocess,d016212,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4440819'],['tgf-beta activates both smad signaling and the ras -- erk pathway.'],1,100.0,40.0,1.0,140.0
81,erk,bioprocess,d020928,nan,nan,nan,nan,nan,u0126,simple-chemical,chebi:90693,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc4440819'],"['the expression level of alphasma in tgf-beta1-stimulated rle cells was hardly affected by treatment with u0126, which inhibits the erk pathway (xref_fig).']",1,100.0,40.0,1.0,140.0
68,erk,bioprocess,d020928,nan,nan,nan,nan,nan,hgf,protein,p14210,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4440819'],"['furthermore, these conclusions are in line with the previous findings that the ras -- erk pathway induced by hepatocyte growth factor (hgf) or fgf1 interferes with tgf-beta1-induced emt in primary cultured aecs and aec cell lines [xref_bibr, xref_bib']",1,100.0,40.0,1.0,140.0
172,raf,nan,nan,nan,nan,nan,nan,nan,fgf2,protein,p09038,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4440819'],"['in contrast, fgf2 stimulation or overexpression of constitutively active ras, raf, or mek enhances the activity of the tgf-beta1-induced ras -- erk pathway.']",1,100.0,40.0,1.0,140.0
64,erk,bioprocess,d020928,nan,nan,nan,nan,nan,da-raf,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc4440819'],"['since da-raf does not directly affect smad2/3 signaling but suppresses the tgf-beta1-induced non smad ras -- erk pathway, the information obtained in this study might provide ideas to treatment for pulmonary fibrosis without loss of the other importa']",1,100.0,40.0,1.0,140.0
63,erk,bioprocess,d020928,nan,nan,nan,nan,nan,araf,protein,p10398,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc2064279'],"['furthermore, overexpressed da-raf1 abrogated erk activation, whereas the knockdown of da-raf facilitated erk activation.']",1,100.0,40.0,1.0,140.0
122,mek,nan,nan,nan,nan,nan,nan,nan,braf,protein,p15056,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc2064279'],['these results are compatible with the notion that b-raf is the main activator of mek in most cell types.'],1,100.0,40.0,1.0,140.0
123,mek,nan,nan,nan,nan,nan,nan,nan,fgf2,protein,p09038,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4440819'],"['in contrast, fgf2 stimulation or overexpression of constitutively active ras, raf, or mek enhances the activity of the tgf-beta1-induced ras -- erk pathway.']",1,100.0,40.0,1.0,140.0
124,mek,nan,nan,nan,nan,nan,nan,nan,ksr,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4020307'],"['the scaffold protein ksr (kinase suppressor of ras) helps in raf activation, but also contributes to the sequential phosphorylation steps of the mapk cascade by bringing together mapk components, raf, mek and erk and mapk.']",1,100.0,40.0,1.0,140.0
125,mek,nan,nan,nan,nan,nan,nan,nan,pebp1,protein,p30086,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc2064279'],['both spry and rkip bind to raf to inhibit the erk pathway by preventing the binding of mek.'],1,100.0,40.0,1.0,140.0
127,mek,nan,nan,nan,nan,nan,nan,nan,selumetinib,simple-chemical,chebi:90227,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc4179759'],['preclinical data have demonstrated that mek inhibition by selumetinib is one of the effective strategies for targeting dysregulated mapk pathway that leads to unregulated cell proliferation and development and progression of melanoma.'],1,100.0,40.0,1.0,140.0
128,mek,nan,nan,nan,nan,nan,nan,nan,tgfb1,protein,p01137,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4440819'],"['knockdown of da-raf expression with sirnas facilitated the activity of mek and erk, which were only weakly and transiently activated by tgf-beta1.']",1,100.0,40.0,1.0,140.0
69,erk,bioprocess,d020928,nan,nan,nan,nan,nan,ier3,protein,p46695,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc2911390'],"['these include multiple transcription factors and targets of erk signaling such as fos and ier3 as well as mapk-phosphatases and sprouty genes involved in feedback inhibition of mek and erk signaling (dual specificity phosphatases 6 (dusp6), dusp1, du']",1,100.0,40.0,1.0,140.0
140,nan,nan,nan,nan,nan,nan,nan,nan,erk,bioprocess,d020928,nan,nan,nan,nan,nan,nan,nan,i,"['nan', 'nan', 'nan', 'nan', 'nan', 'nan']","['phosphorylation', 'phosphorylation', 'phosphorylation', 'phosphorylation', 'phosphorylation', 'phosphorylation']","['pmc2911390', 'pmc3843736', 'pmc4067595', 'pmc4179759', 'pmc4254013', 'pmc4440819']","['nan', 'nan', 'nan', 'nan', 'nan', 'nan']",6,1.0,40.0,1.0,46.0
55,epithelial to mesenchymal transition,bioprocess,go:0001837,nan,nan,nan,nan,nan,mek,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,"['nan', 'nan']","['activation', 'inhibition']","['pmc4440819', 'pmc4440819']","['in addition, inhibition of mek with u0126 prevented emt in these cells.', 'therefore, strong and sustained activation of mek and erk negatively regulates emt in rle cells.']",2,1.0,40.0,1.0,42.0
189,ras,family,pf00071,nan,nan,nan,nan,nan,mek,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,"['nan', 'nan']","['activation', 'activation']","['pmc2911390', 'pmc4440819']","['the ras pathway signature is upregulated in breast cancer cell lines that have acquired resistance to akt inhibition, and is downregulated by inhibition of mek.', 'in contrast, fgf2 stimulation or overexpression of constitutively active ras, raf, or mek enhances the activity of the tgf-beta1-induced ras -- erk pathway.']",2,1.0,40.0,1.0,42.0
25,braf,protein,p15056,nan,nan,nan,nan,nan,erk,bioprocess,d020928,nan,nan,nan,nan,nan,nan,nan,i,"['nan', 'nan']","['inhibition', 'dephosphorylation']","['pmc4179759', 'pmc4254013']","['phosphorylation of erk1/2, downstream molecules of mek, was effectively inhibited with selumetinib in melanoma, colorectal cancer, pancreatic cancer, non-small-cell lung cancer, and hepatocellular cancer cell lines harboring braf, nras, or kras mutat', 'nan']",2,1.0,40.0,1.0,42.0
160,pd 0325901,simple-chemical,chebi:88249,nan,nan,nan,nan,nan,erk,bioprocess,d020928,nan,nan,nan,nan,nan,nan,nan,i,"['nan', 'nan']","['dephosphorylation', 'phosphorylation']","['pmc3843736', 'pmc3843736']","['nan', 'nan']",2,1.0,40.0,1.0,42.0
43,cell population proliferation,bioprocess,go:0008283,nan,nan,nan,nan,nan,erk,bioprocess,d020928,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc2064279'],"['for instance, the growth factor induced activation of ras leads to erk pathway mediated cell proliferation and morphogenesis during animal development.']",1,1.0,40.0,1.0,41.0
98,kras,protein,p01116,nan,nan,nan,nan,nan,erk,bioprocess,d020928,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc4179759'],"['phosphorylation of erk1/2, downstream molecules of mek, was effectively inhibited with selumetinib in melanoma, colorectal cancer, pancreatic cancer, non-small-cell lung cancer, and hepatocellular cancer cell lines harboring braf, nras, or kras mutat']",1,1.0,40.0,1.0,41.0
156,nras,protein,p01111,nan,nan,nan,nan,nan,erk,bioprocess,d020928,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc4179759'],"['phosphorylation of erk1/2, downstream molecules of mek, was effectively inhibited with selumetinib in melanoma, colorectal cancer, pancreatic cancer, non-small-cell lung cancer, and hepatocellular cancer cell lines harboring braf, nras, or kras mutat']",1,1.0,40.0,1.0,41.0
177,raf1,protein,p04049,nan,nan,nan,nan,nan,erk,bioprocess,d020928,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['phosphorylation'],['pmc4254013'],['nan'],1,1.0,40.0,1.0,41.0
56,epithelial to mesenchymal transition,bioprocess,go:0001837,nan,nan,nan,nan,nan,raf,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4440819'],"['in addition, active ras or raf induces emt cooperatively with tgf-beta1 in canine kidney epithelial cells and mouse mammary epithelial cells [xref_bibr, xref_bibr].']",1,1.0,40.0,1.0,41.0
143,nan,nan,nan,nan,nan,nan,nan,nan,mek,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['phosphorylation'],['pmc4440819'],['nan'],1,1.0,40.0,1.0,41.0
53,epithelial to mesenchymal transition,bioprocess,go:0001837,nan,nan,nan,nan,nan,erk,bioprocess,d020928,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc4440819'],"['the growth factor induced ras -- erk pathway impedes emt in aecs through the expression of the smad signaling inhibitor smad7, the nuclear export of smad7 and the e3 ubiquitin ligase smurf1, or the dephosphorylation of smad2.']",1,1.0,40.0,1.0,41.0
178,raf1,protein,p04049,nan,nan,nan,nan,nan,mek,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['phosphorylation'],['pmc2064279'],['nan'],1,1.0,40.0,1.0,41.0
75,erk,bioprocess,d020928,nan,nan,nan,nan,nan,raf,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,"['nan', 'nan', 'nan', 'nan']","['activation', 'activation', 'inhibition', 'inhibition']","['pmc2064279', 'pmc4440819', 'pmc4440819', 'pmc4440819']","['activation of the raf mediated erk pathway by oncogenic ras induces transformation in mouse fibroblasts.', 'in contrast, fgf2 stimulation or overexpression of constitutively active ras, raf, or mek enhances the activity of the tgf-beta1-induced ras -- erk pathway.', 'both sprouty and rkip bind to raf to inhibit the erk pathway by preventing the binding of mek.', 'both sprouty and rkip bind to raf to inhibit the erk pathway by preventing the binding of mek.']",4,10.0,1.0,1.0,41.0
223,zr-75-1r,nan,nan,nan,nan,nan,nan,nan,erk,bioprocess,d020928,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['phosphorylation'],['pmc2911390'],['nan'],1,1.0,40.0,1.0,41.0
21,araf,protein,p10398,nan,nan,nan,nan,nan,mek,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['phosphorylation'],['pmc2064279'],['nan'],1,1.0,40.0,1.0,41.0
217,tgfb,bioprocess,d016212,nan,nan,nan,nan,nan,erk,bioprocess,d020928,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc4440819'],"['among them, conditional deletion of sprouty in lens epithelial cells increases erk phosphorylation, elevates tgf-beta signaling, and promotes tgf-beta-induced emt [xref_bibr].']",1,1.0,40.0,1.0,41.0
203,selumetinib,simple-chemical,chebi:90227,nan,nan,nan,nan,nan,erk,bioprocess,d020928,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['dephosphorylation'],['pmc4179759'],['nan'],1,1.0,40.0,1.0,41.0
213,sprouty,family,pf05210,nan,nan,nan,nan,nan,erk,bioprocess,d020928,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['dephosphorylation'],['pmc4440819'],['nan'],1,1.0,40.0,1.0,41.0
206,smad,nan,nan,nan,nan,nan,nan,nan,erk,bioprocess,d020928,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4440819'],"['tgf-beta induces both canonical smad signaling and non canonical signaling, including the ras induced erk pathway (raf-mek-erk).']",1,1.0,40.0,1.0,41.0
193,ras,family,pf00071,nan,nan,nan,nan,nan,raf,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4440819'],"['in contrast, fgf2 stimulation or overexpression of constitutively active ras, raf, or mek enhances the activity of the tgf-beta1-induced ras -- erk pathway.']",1,1.0,40.0,1.0,41.0
32,cd40,protein,p25942,nan,nan,nan,nan,nan,mek,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['increaseamount'],['pmc3809567'],"['the expression of cd40, cd80, cd83, and mhci was also reduced by direct mek inhibition, whereas it was unaffected by braf inhibition.']",1,1.0,40.0,1.0,41.0
150,nan,nan,nan,nan,nan,nan,nan,nan,stat3,protein,p40763,nan,nan,nan,nan,nan,nan,nan,i,"['nan', 'nan', 'nan']","['phosphorylation', 'phosphorylation', 'phosphorylation']","['pmc3843736', 'pmc3843736', 'pmc3843736']","['nan', 'nan', 'nan']",3,0.1,40.0,1.0,40.3
141,nan,nan,nan,nan,nan,nan,nan,nan,ksr,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,"['nan', 'nan', 'nan']","['phosphorylation', 'phosphorylation', 'phosphorylation']","['pmc4020307', 'pmc4020307', 'pmc4020307']","['nan', 'nan', 'nan']",3,0.1,40.0,1.0,40.3
103,malonaldehyde,simple-chemical,chebi:566274,nan,nan,nan,nan,nan,braf,protein,p15056,nan,nan,nan,nan,nan,nan,nan,i,"['nan', 'nan']","['decreaseamount', 'inhibition']","['pmc3809567', 'pmc3809567']","['it has been suggested that oncogenic braf suppresses mda expression through microphthalmia associated transcription factor.', 'this observation was specific to braf mutant tumors and independent of braf inhibition mediated upregulation of mda.']",2,0.1,40.0,1.0,40.2
62,epithelial to mesenchymal transition,bioprocess,go:0001837,nan,nan,nan,nan,nan,tgfb1,protein,p01137,nan,nan,nan,nan,nan,nan,nan,i,"['nan', 'nan']","['activation', 'inhibition']","['pmc4440819', 'pmc4440819']","['taken together, these results indicate that da-raf is required for the induction of emt by tgf-beta1 in rle cells.', 'these results imply that the low levels of transient activation of mek and erk, which are brought about by tgf- beta 1 treatment, do not inhibit emt, but that the fgf2 induced high levels of sustained activation of mek and erk suppress tgf- beta 1 in']",2,0.1,40.0,1.0,40.2
9,alphasma,nan,nan,nan,nan,nan,nan,nan,map2k1,protein,q02750,nan,nan,nan,nan,nan,nan,nan,i,"['nan', 'nan']","['decreaseamount', 'decreaseamount']","['pmc4440819', 'pmc4440819']","['similarly, transfection of mek1 (s218d and s222d), a constitutively active pseudophosphorylation mutant [xref_bibr], noticeably suppressed alphasma expression (fig xref_fig and xref_fig).', 'similarly, transfection of mek1 (s218d and s222d), a constitutively active pseudophosphorylation mutant [xref_bibr], noticeably suppressed alphasma expression (fig xref_fig and xref_fig).']",2,0.1,40.0,1.0,40.2
196,ras,family,pf00071,nan,nan,nan,nan,nan,stat3,protein,p40763,nan,nan,nan,nan,nan,nan,nan,i,"['nan', 'nan']","['phosphorylation', 'phosphorylation']","['pmc3843736', 'pmc3843736']","['nan', 'nan']",2,0.1,40.0,1.0,40.2
139,nan,nan,nan,nan,nan,nan,nan,nan,akt,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,"['nan', 'nan']","['phosphorylation', 'phosphorylation']","['pmc2911390', 'pmc3843736']","['nan', 'nan']",2,0.1,40.0,1.0,40.2
207,smad,nan,nan,nan,nan,nan,nan,nan,ras,family,pf00071,nan,nan,nan,nan,nan,nan,nan,i,"['nan', 'nan']","['activation', 'increaseamount']","['pmc4440819', 'pmc4440819']","['besides canonical smad signaling, tgf-beta induces non canonical, non smad signaling including the ras -- erk pathway, traf6 -- tak1 -- jnk and p38 mapk, rhoa and cdc42, and pi3k -- akt signaling [xref_bibr - xref_bibr].', 'on the other hand, the ras -- erk pathway cooperates with tgf-beta to induce smad dependent expression of snail1, which is required for emt through repressing e-cadherin expression [xref_bibr].']",2,0.1,40.0,1.0,40.2
110,mapk,bioprocess,d020928,nan,nan,nan,nan,nan,ksr,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,"['nan', 'nan']","['activation', 'inhibition']","['pmc4020307', 'pmc4020307']","['the scaffold protein ksr (kinase suppressor of ras) helps in raf activation, but also contributes to the sequential phosphorylation steps of the mapk cascade by bringing together mapk components, raf, mek and erk and mapk.', 'as a result, ksr is released of the inhibition exerted by 14-3-3 and translocates to the plasma membrane to promote mapk pathway activation.']",2,0.1,40.0,1.0,40.2
142,nan,nan,nan,nan,nan,nan,nan,nan,ksr1,protein,q8ivt5,nan,nan,nan,nan,nan,nan,nan,i,"['nan', 'nan']","['phosphorylation', 'phosphorylation']","['pmc4020307', 'pmc4020307']","['nan', 'nan']",2,0.1,40.0,1.0,40.2
57,epithelial to mesenchymal transition,bioprocess,go:0001837,nan,nan,nan,nan,nan,ras,family,pf00071,nan,nan,nan,nan,nan,nan,nan,i,"['nan', 'nan']","['activation', 'inhibition']","['pmc4440819', 'pmc4440819']","['therefore, although the ras -- erk pathway positively regulates tgf-beta1-induced emt in several or many cell types, it negatively regulates in aecs including rle cells.', 'these results corroborate the above notion that strong and sustained activation of the ras -- erk pathway blocks emt in rle cells.']",2,0.1,40.0,1.0,40.2
54,epithelial to mesenchymal transition,bioprocess,go:0001837,nan,nan,nan,nan,nan,fgf2,protein,p09038,nan,nan,nan,nan,nan,nan,nan,i,"['nan', 'nan']","['activation', 'inhibition']","['pmc4440819', 'pmc4440819']","['consequently, fgf2 induced strong and sustained activation of the ras -- erk pathway (see xref_fig) but not pi3k -- akt signaling hinders emt.', 'to determine whether only the ras -- erk pathway or whether both the ras -- erk pathway and pi3k -- akt signaling are responsible for the fgf2 caused suppression of emt, we analyzed the effects of inhibitors of these signaling pathways in rle cells.']",2,0.1,40.0,1.0,40.2
51,endocytosis,bioprocess,go:0006897,nan,nan,nan,nan,nan,dnm,bioprocess,d034281,nan,nan,nan,nan,nan,nan,nan,i,"['nan', 'nan']","['activation', 'inhibition']","['pmc4020307', 'pmc4020307']","['arf6 by recruiting nm23-h1 was reported to facilitate dynamin mediated endocytosis during adherens junctions disassembly and nm23-h1 was suggested to provide a source of gtp for arf6 [xref_bibr].', 'awd functions as a negative regulator of cell migration in tracheal and border cells by downregulating receptor levels on the cell surface through dynamin mediated endocytosis [xref_bibr, xref_bibr], thus it suppresses cell motility through receptor ']",2,0.1,40.0,1.0,40.2
220,"transcription, dna-templated",bioprocess,go:0006351,nan,nan,nan,nan,nan,ras-erk,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,"['nan', 'nan']","['activation', 'inhibition']","['pmc2064279', 'pmc2064279']","['the ras-erk pathway negatively regulates skeletal muscle cell differentiation by suppressing the expression or functions of the muscle specific transcription factors myod and mef2.', 'the ras-erk pathway negatively regulates muscle specific gene expression by interfering with the expression of the myod family and mef2 family transcription factors.']",2,0.1,40.0,1.0,40.2
188,ras,family,pf00071,nan,nan,nan,nan,nan,ksr,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,"['nan', 'nan']","['inhibition', 'activation']","['pmc4020307', 'pmc4020307']","['the scaffold protein ksr (kinase suppressor of ras) helps in raf activation, but also contributes to the sequential phosphorylation steps of the mapk cascade by bringing together mapk components, raf, mek and erk and mapk.', 'thus, upon ras activation ksr brings mek to the plasma membrane in close proximity to the raf kinase.']",2,0.1,40.0,1.0,40.2
153,neoplasm invasiveness,bioprocess,d009361,nan,nan,nan,nan,nan,vegf,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc3809567'],"['it was previously shown that vegf and vegfr -2 inhibition can upregulate endothelial adhesion molecules in tumor vessels, which can in turn increase the infiltration of leukocytes in tumors.']",1,0.1,40.0,1.0,40.1
154,neoplasm invasiveness,bioprocess,d009361,nan,nan,nan,nan,nan,vegfr,bioprocess,go:0005172,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc3809567'],"['it was previously shown that vegf and vegfr -2 inhibition can upregulate endothelial adhesion molecules in tumor vessels, which can in turn increase the infiltration of leukocytes in tumors.']",1,0.1,40.0,1.0,40.1
155,neoplasm metastasis,bioprocess,d009362,nan,nan,nan,nan,nan,nme1,protein,p15531,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc4020307'],['the metastasis suppressor nm23 as a modulator of ras and erk signaling.'],1,0.1,40.0,1.0,40.1
215,stat3,protein,p40763,nan,nan,nan,nan,nan,pd 0325901,simple-chemical,chebi:88249,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc3843736'],"['stat3 ps727 was completely inhibited by all tested doses of pd0325901 without affecting total stat3 expression, again paralleling the observations in mouse cells (compare xref_fig).']",1,0.1,40.0,1.0,40.1
214,stat3,protein,p40763,nan,nan,nan,nan,nan,elf4,protein,q99607,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc3843736'],"['activation of each single pathway is sufficient to induce limited cell transformation in vitro, and we have previously found that transformation of murine embryo fibroblasts (mef) in vitro by each ras activated pathway is stat3 dependent [xref_bibr].']",1,0.1,40.0,1.0,40.1
152,necrotic cell death,bioprocess,go:0070265,nan,nan,nan,nan,nan,vegf,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc3809567'],"['several mechanisms that may account for the improved immune response have been described such as increased mda expression on melanoma cells and decreased intra-tumoral vegf production, others remain speculative, such as increased cross presentation t']",1,0.1,40.0,1.0,40.1
151,necrotic cell death,bioprocess,go:0070265,nan,nan,nan,nan,nan,braf,protein,p15056,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc3809567'],['braf inhibition does however eventually induce apoptosis and necrosis as evident by the fact that tumors shrink markedly in the majority of patients.'],1,0.1,40.0,1.0,40.1
157,nras,protein,p01111,nan,nan,nan,nan,nan,gef,bioprocess,go:0008433,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4440819'],"['the rtk mediated activation of a specific gef activates the small gtpase ras (h-, k-, and n-ras) via gtp loading.']",1,0.1,40.0,1.0,40.1
158,p14_3_3,family,pf00244,nan,nan,nan,nan,nan,ksr1,protein,q8ivt5,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['phosphorylation'],['pmc4020307'],['nan'],1,0.1,40.0,1.0,40.1
159,panitumumab,nan,nan,nan,nan,nan,nan,nan,egfr,protein,p00533,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc2911390'],"['for example, kras mutations are associated with decreased disease control rate, shorter progression-free survival and reduced overall survival in patients with advanced or metastatic colorectal cancer treated with the egfr targeting antibodies cetuxi']",1,0.1,40.0,1.0,40.1
149,nan,nan,nan,nan,nan,nan,nan,nan,smad2_3,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['phosphorylation'],['pmc4440819'],['nan'],1,0.1,40.0,1.0,40.1
187,ras,family,pf00071,nan,nan,nan,nan,nan,guanine,simple-chemical,chebi:16235,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4067595'],"['ras activation is catalyzed by guanine nucleotide exchange factors (gefs), such as son of sevenless (sos), which displace gdp and allow gtp to preferentially occupy the vacant nucleotide binding site due to its relative abundance in the cytoplasm.']",1,0.1,40.0,1.0,40.1
148,nan,nan,nan,nan,nan,nan,nan,nan,smad2,protein,q15796,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['dephosphorylation'],['pmc4440819'],['nan'],1,0.1,40.0,1.0,40.1
136,myhc,nan,nan,nan,nan,nan,nan,nan,araf,protein,p10398,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc2064279'],['the transfection of daraf1 also elevated the ratio of myhc expressing cells (xref_fig) and tnt expressing cells (xref_fig) two- to several fold during differentiation.'],1,0.1,40.0,1.0,40.1
134,mtor,protein,p42345,nan,nan,nan,nan,nan,ps727,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc3843736'],"['however, ps727 was unaffected by inhibition of mtor with rapamycin or inhibition of the pi3k-akt pathway with ly294002, in spite of effective inhibition of their characteristic targets, s6k and akt (xref_fig, lanes 2 and 3).']",1,0.1,40.0,1.0,40.1
222,tumor microenvironment,bioprocess,d059016,nan,nan,nan,nan,nan,mapk,bioprocess,d020928,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc3809567'],['mapk inhibition may enhance dc function in the tumor microenvironment by several mechanisms.'],1,0.1,40.0,1.0,40.1
221,"transcription, dna-templated",bioprocess,go:0006351,nan,nan,nan,nan,nan,smad2,protein,q15796,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4440819'],"['furthermore, da-raf knockdown impaired the tgf-beta1-induced nuclear translocation of smad2, which mediates the transcription required for emt.']",1,0.1,40.0,1.0,40.1
135,mvd,protein,p53602,nan,nan,nan,nan,nan,nf1,protein,p21359,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4067595'],"['bi-allelic inactivation of nf1 induces an mpd, which can be progressed to aml using retro-viral mutagenesis to induce secondary genetic aberrations.']",1,0.1,40.0,1.0,40.1
219,tnnt1,protein,p13805,nan,nan,nan,nan,nan,araf,protein,p10398,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc2064279'],['the transfection of daraf1 also elevated the ratio of myhc expressing cells (xref_fig) and tnt expressing cells (xref_fig) two- to several fold during differentiation.'],1,0.1,40.0,1.0,40.1
218,tgfb,bioprocess,d016212,nan,nan,nan,nan,nan,smad,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4440819'],"['combination or crosstalk of these non smad signaling pathways or between smad and non smad signaling produces diverse biological responses of tgf-beta, such as cell proliferation, differentiation, growth arrest, apoptosis, and emt.']",1,0.1,40.0,1.0,40.1
137,myod1,protein,p15172,nan,nan,nan,nan,nan,ras-erk,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc2064279'],['the ras-erk pathway negatively regulates skeletal muscle cell differentiation by suppressing the expression or functions of the muscle specific transcription factors myod and mef2.'],1,0.1,40.0,1.0,40.1
147,nan,nan,nan,nan,nan,nan,nan,nan,shc1,protein,p29353,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['phosphorylation'],['pmc4440819'],['nan'],1,0.1,40.0,1.0,40.1
138,myog,protein,p15173,nan,nan,nan,nan,nan,araf,protein,p10398,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc2064279'],['the effects of daraf1 transfection to induce myogenin and the late muscle specific proteins were more obvious around 48-72 h after the transfection than at later time points probably because of the up-regulation of endogenous da-raf1 protein in contr'],1,0.1,40.0,1.0,40.1
216,stat3,protein,p40763,nan,nan,nan,nan,nan,ras,family,pf00071,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['phosphorylation'],['pmc3843736'],['nan'],1,0.1,40.0,1.0,40.1
162,pi3k,nan,nan,nan,nan,nan,nan,nan,cdk4,protein,p11802,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4179759'],"['xref_bibr, xref_bibr one of the possible explanations for the failed anticancer activity is that nras mutations activate multiple pathways including cdk4 driven cell-cycle progression and pi3k and akt signaling in addition to mapk pathway.']",1,0.1,40.0,1.0,40.1
144,nan,nan,nan,nan,nan,nan,nan,nan,mlo7,protein,o22752,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['phosphorylation'],['pmc4020307'],['nan'],1,0.1,40.0,1.0,40.1
145,nan,nan,nan,nan,nan,nan,nan,nan,raf1,protein,p04049,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['phosphorylation'],['pmc4020307'],['nan'],1,0.1,40.0,1.0,40.1
146,nan,nan,nan,nan,nan,nan,nan,nan,receptor-activated smad,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['phosphorylation'],['pmc4440819'],['nan'],1,0.1,40.0,1.0,40.1
161,phosphoinositol-3-kinase,nan,nan,nan,nan,nan,nan,nan,ras,family,pf00071,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc3843736'],"['ras engages numerous signaling pathways to elicit its tumorigenic activities, primarily the mek-erk, phosphoinositol-3-kinase (pi3k), and ral pathways [xref_bibr].']",1,0.1,40.0,1.0,40.1
168,proteasome,bioprocess,go:0000502,nan,nan,nan,nan,nan,ksr,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4020307'],"['hsp90 is a binding partner of ksr, which might promote the proteasome mediated degradation of ksr, thus attenuating erk signaling.']",1,0.1,40.0,1.0,40.1
163,pi3k,nan,nan,nan,nan,nan,nan,nan,fgf2,protein,p09038,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4440819'],"['consequently, fgf2 induced strong and sustained activation of the ras -- erk pathway (see xref_fig) but not pi3k -- akt signaling hinders emt.']",1,0.1,40.0,1.0,40.1
191,ras,family,pf00071,nan,nan,nan,nan,nan,nf1,protein,p21359,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc4067595'],"['the nf1 gene encodes neurofibromin (nf1), a gap that inhibits ras signaling by stimulating hydrolysis of active ras-gtp into inactive ras-gdp.']",1,0.1,40.0,1.0,40.1
197,ras,family,pf00071,nan,nan,nan,nan,nan,tgf- beta,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4440819'],"['tgf- beta also induces both the ras -- erk pathway and pi3k -- akt signaling as non smad signaling [xref_bibr, xref_bibr].']",1,0.1,40.0,1.0,40.1
132,mek-erk inhibitors,nan,nan,nan,nan,nan,nan,nan,stat3,protein,p40763,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['phosphorylation'],['pmc3843736'],['nan'],1,0.1,40.0,1.0,40.1
195,ras,family,pf00071,nan,nan,nan,nan,nan,sos,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4020307'],['rtks often signal to the ras and erk cascade via grb-2 (growth factor receptor bound protein 2) and the guanine nucleotide exchange factor (gef) sos (son of sevenless) to activate the small gtpase ras.'],1,0.1,40.0,1.0,40.1
175,raf-mek-erk,nan,nan,nan,nan,nan,nan,nan,ras,family,pf00071,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc3843736'],"['therefore, to define whether ras activation of the raf-mek-erk pathway and the consequent s727 phospohorylation of the mitochondrial pool of stat3 was important for transformation, we performed colony assays as a measure of anchorage independent cell']",1,0.1,40.0,1.0,40.1
176,raf-mek-erk,nan,nan,nan,nan,nan,nan,nan,stat3,protein,p40763,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['phosphorylation'],['pmc3843736'],['nan'],1,0.1,40.0,1.0,40.1
194,ras,family,pf00071,nan,nan,nan,nan,nan,rgs19,protein,p49795,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc4020307'],['recently pioneering work has shown that in hek293 cells rgs19 (regulator of g protein signaling 19) is able to suppress ras signaling through upregulation of nm23 expression and nm23 mediated phosphorylation of ksr [xref_bibr].'],1,0.1,40.0,1.0,40.1
192,ras,family,pf00071,nan,nan,nan,nan,nan,nme1,protein,p15531,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc4020307'],"['overexpression of nm23-h1 in mda-mb-435 breast carcinoma cells resulted in decreased activated mapk (pmapk) levels without affecting the level of total mapk, suggesting that nm23-h1 inhibits ras and mapk signaling through ksr phosphorylation and inac']",1,0.1,40.0,1.0,40.1
190,ras,family,pf00071,nan,nan,nan,nan,nan,ndpks,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc4020307'],"['thus, ndpks might attenuate ras and erk signaling through phosphorylation (thus inactivation) of ksr scaffolds.']",1,0.1,40.0,1.0,40.1
164,pi3k,nan,nan,nan,nan,nan,nan,nan,mts-stat3-s/d,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc3843736'],"['in addition, expression of mts-stat3-s/d did not increase the ability of activated pi3k signaling to transform cells, although total stat3 stimulated pi3k dependent transformation.']",1,0.1,40.0,1.0,40.1
179,ral,family,pf11058,nan,nan,nan,nan,nan,ralgds,protein,q12967,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc3843736'],"['deregulated pi3k signaling (e.g., loss of the negative regulator pten) is one of the most commonly mutated tumor suppressors seen in cancer, particularly malignancies of the central nervous system and endometrium [ xref ]; constitutive raf signaling ']",1,0.1,40.0,1.0,40.1
180,rala,protein,p11233,nan,nan,nan,nan,nan,ralgds,protein,q12967,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc3843736'],"['deregulated pi3k signaling (e.g., loss of the negative regulator pten) is one of the most commonly mutated tumor suppressors seen in cancer, particularly malignancies of the central nervous system and endometrium [xref_bibr]; constitutive raf signali']",1,0.1,40.0,1.0,40.1
181,ras,family,pf00071,nan,nan,nan,nan,nan,da-raf,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc4440819'],"['we have found da-raf1 (da-raf), which intrinsically antagonizes the ras -- erk pathway [xref_bibr, xref_bibr].']",1,0.1,40.0,1.0,40.1
182,ras,family,pf00071,nan,nan,nan,nan,nan,da-raf1,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc4440819'],"['we have found da-raf1 (da-raf), which intrinsically antagonizes the ras -- erk pathway [xref_bibr, xref_bibr].']",1,0.1,40.0,1.0,40.1
183,ras,family,pf00071,nan,nan,nan,nan,nan,fgf2,protein,p09038,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4440819'],"['consequently, fgf2 induced strong and sustained activation of the ras -- erk pathway (see xref_fig) but not pi3k -- akt signaling hinders emt.']",1,0.1,40.0,1.0,40.1
184,ras,family,pf00071,nan,nan,nan,nan,nan,gap,bioprocess,go:0005096,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc4067595'],"['the nf1 gene encodes neurofibromin (nf1), a gap that inhibits ras signaling by stimulating hydrolysis of active ras-gtp into inactive ras-gdp.']",1,0.1,40.0,1.0,40.1
185,ras,family,pf00071,nan,nan,nan,nan,nan,gef,bioprocess,go:0008433,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4440819'],"['the rtk mediated activation of a specific gef activates the small gtpase ras (h-, k-, and n-ras) via gtp loading.']",1,0.1,40.0,1.0,40.1
198,ras,family,pf00071,nan,nan,nan,nan,nan,tgfb,bioprocess,d016212,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4440819'],['tgf-beta activates both smad signaling and the ras -- erk pathway.'],1,0.1,40.0,1.0,40.1
199,ras-erk,nan,nan,nan,nan,nan,nan,nan,araf,protein,p10398,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc2064279'],['da-raf1 antagonizes the ras-erk pathway.'],1,0.1,40.0,1.0,40.1
200,ras-pi3k-akt,nan,nan,nan,nan,nan,nan,nan,araf,protein,p10398,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc2064279'],"['consequently, the exogenously expressed da-raf1 is likely to antagonize the ras-erk pathway but not ras-pi3k-akt signaling.']",1,0.1,40.0,1.0,40.1
201,rb1,protein,p06400,nan,nan,nan,nan,nan,ras-erk,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc2064279'],"['the ras-erk pathway causes the inactivation of rb by transactivating cyclin d1, which participates in inactivating the phosphorylation of rb by forming the complex with cdk4/6.']",1,0.1,40.0,1.0,40.1
165,pi3k,nan,nan,nan,nan,nan,nan,nan,stat3,protein,p40763,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['phosphorylation'],['pmc3843736'],['nan'],1,0.1,40.0,1.0,40.1
166,pi3k,nan,nan,nan,nan,nan,nan,nan,tgf- beta,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4440819'],"['tgf- beta also induces both the ras -- erk pathway and pi3k -- akt signaling as non smad signaling [xref_bibr, xref_bibr].']",1,0.1,40.0,1.0,40.1
167,ppp2,bioprocess,d054648,nan,nan,nan,nan,nan,ksr1,protein,q8ivt5,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['dephosphorylation'],['pmc4020307'],['nan'],1,0.1,40.0,1.0,40.1
186,ras,family,pf00071,nan,nan,nan,nan,nan,gtpase activating proteins,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc4067595'],"['ras proteins exhibit intrinsic low-level hydrolytic activity and are negatively regulated by gtpase activating proteins (gaps) such as neurofibromin (nf1), which stimulate gtp hydrolysis and formation of inactive ras-gdp.']",1,0.1,40.0,1.0,40.1
169,rac1,protein,p63000,nan,nan,nan,nan,nan,arf6,protein,p62330,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4020307'],"['although the exact mechanism is unknown, nm23-h1 was shown to interact with factors involved in rac1 activation, such as the small gtpase arf6 or the nucleotide exchange factor tiam1 [xref_bibr, xref_bibr].']",1,0.1,40.0,1.0,40.1
170,rac1,protein,p63000,nan,nan,nan,nan,nan,nme1,protein,p15531,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc4020307'],['elevated rac1 level upon nm23 knockdown suggests that nm23 inhibits rac1 activation.'],1,0.1,40.0,1.0,40.1
171,rac1,protein,p63000,nan,nan,nan,nan,nan,tiam1,protein,q13009,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4020307'],"['although the exact mechanism is unknown, nm23-h1 was shown to interact with factors involved in rac1 activation, such as the small gtpase arf6 or the nucleotide exchange factor tiam1 [xref_bibr, xref_bibr].']",1,0.1,40.0,1.0,40.1
212,sos,nan,nan,nan,nan,nan,nan,nan,mapk,bioprocess,d020928,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc3498325'],"['as rasip1 is not included in the kegg and go-terms, these results provide an independent line of evidence of altered mapk signaling in sos.']",1,0.1,40.0,1.0,40.1
211,snail1,nan,nan,nan,nan,nan,nan,nan,ras,family,pf00071,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['increaseamount'],['pmc4440819'],"['on the other hand, the ras -- erk pathway cooperates with tgf-beta to induce smad dependent expression of snail1, which is required for emt through repressing e-cadherin expression [xref_bibr].']",1,0.1,40.0,1.0,40.1
210,smad ras,nan,nan,nan,nan,nan,nan,nan,da-raf,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc4440819'],"['since da-raf does not directly affect smad2/3 signaling but suppresses the tgf-beta1-induced non smad ras -- erk pathway, the information obtained in this study might provide ideas to treatment for pulmonary fibrosis without loss of the other importa']",1,0.1,40.0,1.0,40.1
209,smad,nan,nan,nan,nan,nan,nan,nan,tgfb,bioprocess,d016212,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4440819'],"['tgf-beta induces both canonical smad signaling and non canonical signaling, including the ras induced erk pathway (raf-mek-erk).']",1,0.1,40.0,1.0,40.1
208,smad,nan,nan,nan,nan,nan,nan,nan,smad7,protein,o15105,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc4440819'],"['this interference may be achieved directly by phosphorylation of the linker regions of smad2/3 [xref_bibr, xref_bibr] or indirectly by inducing expression of smad7, an inhibitor of tbetari -- smad2/3 interaction, and transport of smad7 and smurf1, an']",1,0.1,40.0,1.0,40.1
205,signaling,nan,nan,nan,nan,nan,nan,nan,nme1,protein,p15531,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc4020307'],"['overexpression of nm23-h1 in mda-mb-435 breast carcinoma cells resulted in decreased activated mapk (pmapk) levels without affecting the level of total mapk, suggesting that nm23-h1 inhibits ras/mapk signaling through ksr phosphorylation and inactiva']",1,0.1,40.0,1.0,40.1
204,signaling,nan,nan,nan,nan,nan,nan,nan,gap,bioprocess,go:0005096,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc4067595'],"['the nf1 gene encodes neurofibromin (nf1), a gap that inhibits ras signaling by stimulating hydrolysis of active ras–gtp into inactive ras–gdp.']",1,0.1,40.0,1.0,40.1
202,selumetinib,simple-chemical,chebi:90227,nan,nan,nan,nan,nan,akt,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4179759'],"['xref_bibr in non-small-cell lung cancer cell lines, selumetinib resistance was mediated by a high level of akt activity, and the resistance was reversed by akt inhibition.']",1,0.1,40.0,1.0,40.1
133,mitf,protein,o75030,nan,nan,nan,nan,nan,histone deacetylase inhibitors,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4179759'],"['xref_bibr because mek independent resistance is not sensitive to mek inhibitor monotherapy, the combined inhibition of mek inhibitors and akt inhibitors or mek inhibitors plus histone deacetylase inhibitors suppressing mitf may reverse the resistance']",1,0.1,40.0,1.0,40.1
0,5-bromo-2'-deoxyuridine,simple-chemical,chebi:472552,nan,nan,nan,nan,nan,araf,protein,p10398,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc2064279'],['daraf1 expression markedly reduced the ratio of brdu incorporating cells (xref_fig).'],1,0.1,40.0,1.0,40.1
131,mek-erk,nan,nan,nan,nan,nan,nan,nan,stat3,protein,p40763,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['phosphorylation'],['pmc3843736'],['nan'],1,0.1,40.0,1.0,40.1
38,cell differentiation,bioprocess,go:0030154,nan,nan,nan,nan,nan,araf,protein,p10398,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc2064279'],['these results suggest the possibility that da-raf1 positively regulates skeletal muscle cell differentiation.'],1,0.1,40.0,1.0,40.1
28,braf,protein,p15056,nan,nan,nan,nan,nan,selumetinib,simple-chemical,chebi:90227,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4179759'],"['xref_bibr, xref_bibr another preclinical study demonstrated that the combination of selumetinib and a mammalian target of rapamycin (mtor) inhibitor (azd8055) which is downstream of pi3k and akt pathway, induces tumor regression in braf mutant uveal ']",1,0.1,40.0,1.0,40.1
29,cascade,nan,nan,nan,nan,nan,nan,nan,nme1,protein,p15531,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc4020307'],"['in this review i summarize how nm23-h1 inhibits the ras/erk cascade in human cell lines, and examine how the nm23 homolog ndk-1 modifies the outcome of ras signaling in the model organism caenorhabditis elegans [ xref ].']",1,0.1,40.0,1.0,40.1
30,cascade,nan,nan,nan,nan,nan,nan,nan,ras,family,pf00071,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc3498325'],"['since it was shown that golgi-associated ras was able to activate the mapk signaling cascade in a timely and quantitatively different manner, it was proposed that compartmentalized ras signaling would increase the complexity of possibilities for down']",1,0.1,40.0,1.0,40.1
31,cd4,protein,p01730,nan,nan,nan,nan,nan,braf,protein,p15056,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc3809567'],['similar increases in tumor infiltration by cd8 cells (but not cd4 cells) and decrease upon tumor progression in melanoma patients treated with braf or dual braf and mek inhibition was reported by frederick et al..'],1,0.1,40.0,1.0,40.1
33,cdh1,protein,p12830,nan,nan,nan,nan,nan,daraf sirnas,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['increaseamount'],['pmc4440819'],"['in contrast, expression of either of the daraf sirnas interfered with the reduction of cdh1 mrna and elevated the cdh1 mrna level in comparison with that in control sirna expressing cells (xref_fig).']",1,0.1,40.0,1.0,40.1
34,cdh1,protein,p12830,nan,nan,nan,nan,nan,tgfb1,protein,p01137,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['decreaseamount'],['pmc4440819'],"['tgf-beta1 treatment reduced the e-cadherin protein level, whereas the level was hardly affected in daraf sirna introduced cells (xref_fig).']",1,0.1,40.0,1.0,40.1
35,cell adhesion,bioprocess,go:0007155,nan,nan,nan,nan,nan,vegf,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc3809567'],"['it was previously shown that vegf and vegfr -2 inhibition can upregulate endothelial adhesion molecules in tumor vessels, which can in turn increase the infiltration of leukocytes in tumors.']",1,0.1,40.0,1.0,40.1
36,cell adhesion,bioprocess,go:0007155,nan,nan,nan,nan,nan,vegfr,bioprocess,go:0005172,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc3809567'],"['it was previously shown that vegf and vegfr -2 inhibition can upregulate endothelial adhesion molecules in tumor vessels, which can in turn increase the infiltration of leukocytes in tumors.']",1,0.1,40.0,1.0,40.1
37,cell cycle,bioprocess,go:0007049,nan,nan,nan,nan,nan,cell differentiation,bioprocess,go:0030154,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc2064279'],"['skeletal muscle cell differentiation necessitates irreversible cell cycle arrest in g 0 phase, the expression of a battery of muscle specific genes, and cell fusion to form multinucleated myotubes.']",1,0.1,40.0,1.0,40.1
39,cell differentiation,bioprocess,go:0030154,nan,nan,nan,nan,nan,myog,protein,p15173,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc2064279'],"['this suppression results in the aborted expression of myogenin, which induces muscle differentiation.']",1,0.1,40.0,1.0,40.1
130,mek-erk,nan,nan,nan,nan,nan,nan,nan,ras,family,pf00071,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc3843736'],"['ras engages numerous signaling pathways to elicit its tumorigenic activities, primarily the mek-erk, phosphoinositol-3-kinase (pi3k), and ral pathways [xref_bibr].']",1,0.1,40.0,1.0,40.1
40,cell differentiation,bioprocess,go:0030154,nan,nan,nan,nan,nan,ngf,protein,p01138,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc2064279'],['this pathway is essential for ngf induced neuronal differentiation in pc12 cells.'],1,0.1,40.0,1.0,40.1
41,cell differentiation,bioprocess,go:0030154,nan,nan,nan,nan,nan,ras,family,pf00071,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc4440819'],"['consequently, da-raf serves as a positive regulator of myogenic differentiation and lung alveolarization, both of which are prevented by the ras -- erk pathway.']",1,0.1,40.0,1.0,40.1
42,cell differentiation,bioprocess,go:0030154,nan,nan,nan,nan,nan,ras-erk,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc2064279'],['the ras-erk pathway negatively regulates skeletal muscle cell differentiation by suppressing the expression or functions of the muscle specific transcription factors myod and mef2.'],1,0.1,40.0,1.0,40.1
44,cell population proliferation,bioprocess,go:0008283,nan,nan,nan,nan,nan,mapk,bioprocess,d020928,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4179759'],['preclinical data have demonstrated that mek inhibition by selumetinib is one of the effective strategies for targeting dysregulated mapk pathway that leads to unregulated cell proliferation and development and progression of melanoma.'],1,0.1,40.0,1.0,40.1
45,cell population proliferation,bioprocess,go:0008283,nan,nan,nan,nan,nan,pi3k,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc3843736'],"['mutation at codons 12, 13 or 61 locks ras in a gtp bound active state, which initiates diverse signaling cascades including raf-mek-erk, pi3k and ral pathways that drive proliferation, survival and angiogenesis [xref_bibr].']",1,0.1,40.0,1.0,40.1
46,cell population proliferation,bioprocess,go:0008283,nan,nan,nan,nan,nan,raf-mek-erk,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc3843736'],"['mutation at codons 12, 13 or 61 locks ras in a gtp bound active state, which initiates diverse signaling cascades including raf-mek-erk, pi3k and ral pathways that drive proliferation, survival and angiogenesis [xref_bibr].']",1,0.1,40.0,1.0,40.1
47,cell population proliferation,bioprocess,go:0008283,nan,nan,nan,nan,nan,rala,protein,p11233,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc3843736'],"['mutation at codons 12, 13 or 61 locks ras in a gtp bound active state, which initiates diverse signaling cascades including raf-mek-erk, pi3k and ral pathways that drive proliferation, survival and angiogenesis [xref_bibr].']",1,0.1,40.0,1.0,40.1
48,daraf gene,nan,nan,nan,nan,nan,nan,nan,araf,protein,p10398,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc2064279'],"['considering that daraf1 is more highly expressed than araf, particularly in the brain and myotubes, da-raf1 is the primary product of the araf and daraf gene by alternative splicing, at least in these tissues and cells.']",1,0.1,40.0,1.0,40.1
49,egfr/ras/erk,nan,nan,nan,nan,nan,nan,nan,egf,protein,p01133,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4020307'],['egf ligand activates the egfr/ras/erk pathway in p (5-7).'],1,0.1,40.0,1.0,40.1
27,braf,protein,p15056,nan,nan,nan,nan,nan,mtor,protein,p42345,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc4179759'],"['xref_bibr, xref_bibr another preclinical study demonstrated that the combination of selumetinib and a mammalian target of rapamycin (mtor) inhibitor (azd8055) which is downstream of pi3k and akt pathway, induces tumor regression in braf mutant uveal ']",1,0.1,40.0,1.0,40.1
26,braf,protein,p15056,nan,nan,nan,nan,nan,mapk,bioprocess,d020928,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc3809567'],"['taken together, these data suggest that mapk pathway activation in braf v600 mutant melanoma cells has a direct suppressive effect on the capacity of dc to activate t cells.']",1,0.1,40.0,1.0,40.1
24,bcl2,protein,p10415,nan,nan,nan,nan,nan,pi3k,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc4067595'],"['for meki, synergism has been demonstrated for pi3k and akt inhibitors, dexamethasone, nutlin-3a, which induces the mdm2-p53 axis, and the bcl-2 and bcl-x (l) inhibitor, navitoclax (abt263).']",1,0.1,40.0,1.0,40.1
23,bcl2,protein,p10415,nan,nan,nan,nan,nan,dexamethasone,simple-chemical,chebi:41879,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc4067595'],"['for meki, synergism has been demonstrated for pi3k and akt inhibitors, dexamethasone, nutlin-3a, which induces the mdm2-p53 axis, and the bcl-2 and bcl-x (l) inhibitor, navitoclax (abt263).']",1,0.1,40.0,1.0,40.1
2,activation,nan,nan,nan,nan,nan,nan,nan,nme1,protein,p15531,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc4020307'],['elevated rac1 level upon nm23 knockdown suggests that nm23 inhibits rac1 activation.'],1,0.1,40.0,1.0,40.1
3,akt,nan,nan,nan,nan,nan,nan,nan,cdk4,protein,p11802,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4179759'],"['xref_bibr, xref_bibr one of the possible explanations for the failed anticancer activity is that nras mutations activate multiple pathways including cdk4 driven cell-cycle progression and pi3k and akt signaling in addition to mapk pathway.']",1,0.1,40.0,1.0,40.1
4,akt,nan,nan,nan,nan,nan,nan,nan,h-rasv12/40c,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc3843736'],"['h-rasv12/35s preferentially signaled through raf-mek-erk, inducing erk phosphorylation (xref_fig, lane 3), whereas h-rasv12/40c activated the pi3k-akt pathway, inducing akt phosphorylation but not erk phosphorylation (xref_fig, lane 4).']",1,0.1,40.0,1.0,40.1
5,akt,nan,nan,nan,nan,nan,nan,nan,tgf- beta,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4440819'],"['tgf- beta also induces both the ras -- erk pathway and pi3k -- akt signaling as non smad signaling [xref_bibr, xref_bibr].']",1,0.1,40.0,1.0,40.1
6,akt,nan,nan,nan,nan,nan,nan,nan,tgfb1,protein,p01137,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4440819'],"['accordingly, the ras -- erk pathway and pi3k -- akt signaling activated by tgf-beta1, even if they are at low levels of activity, seem to be necessary for preventing apoptosis.']",1,0.1,40.0,1.0,40.1
7,alphasma,nan,nan,nan,nan,nan,nan,nan,da-raf,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['increaseamount'],['pmc4440819'],"['on the other hand, knockdown of da-raf with either of the sirnas notably reduced the level of alphasma expression and the ratio of alphasma expressing cells induced by the tgf-beta1 treatment (fig xref_fig and xref_fig).']",1,0.1,40.0,1.0,40.1
8,alphasma,nan,nan,nan,nan,nan,nan,nan,fgf2,protein,p09038,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc4440819'],"['addition of fgf2 dose-dependently decreased the ratio of alphasma expressing cells (xref_fig), and 100 ng/ml fgf2 prominently reduced the ratio of alphasma expressing cells (fig xref_fig and xref_fig).']",1,0.1,40.0,1.0,40.1
10,alphasma,nan,nan,nan,nan,nan,nan,nan,tgfb1,protein,p01137,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4440819'],"['on the other hand, knockdown of da-raf with either of the sirnas notably reduced the level of alphasma expression and the ratio of alphasma expressing cells induced by the tgf-beta1 treatment (fig xref_fig and xref_fig).']",1,0.1,40.0,1.0,40.1
11,alphasma,nan,nan,nan,nan,nan,nan,nan,u0126,simple-chemical,chebi:90693,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4440819'],['u0126 treatment also restored the ratio of alphasma expressing cells nearly to the ratio induced by tgf- beta 1 (xref_fig).'],1,0.1,40.0,1.0,40.1
12,angiogenesis,bioprocess,go:0001525,nan,nan,nan,nan,nan,pi3k,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc3843736'],"['mutation at codons 12, 13 or 61 locks ras in a gtp bound active state, which initiates diverse signaling cascades including raf-mek-erk, pi3k and ral pathways that drive proliferation, survival and angiogenesis [xref_bibr].']",1,0.1,40.0,1.0,40.1
13,angiogenesis,bioprocess,go:0001525,nan,nan,nan,nan,nan,raf-mek-erk,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc3843736'],"['mutation at codons 12, 13 or 61 locks ras in a gtp bound active state, which initiates diverse signaling cascades including raf-mek-erk, pi3k and ral pathways that drive proliferation, survival and angiogenesis [xref_bibr].']",1,0.1,40.0,1.0,40.1
14,angiogenesis,bioprocess,go:0001525,nan,nan,nan,nan,nan,rala,protein,p11233,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc3843736'],"['mutation at codons 12, 13 or 61 locks ras in a gtp bound active state, which initiates diverse signaling cascades including raf-mek-erk, pi3k and ral pathways that drive proliferation, survival and angiogenesis [xref_bibr].']",1,0.1,40.0,1.0,40.1
15,apoptotic process,bioprocess,go:0006915,nan,nan,nan,nan,nan,braf,protein,p15056,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc3809567'],['braf inhibition does however eventually induce apoptosis and necrosis as evident by the fact that tumors shrink markedly in the majority of patients.'],1,0.1,40.0,1.0,40.1
16,apoptotic process,bioprocess,go:0006915,nan,nan,nan,nan,nan,ly294002,simple-chemical,chebi:65329,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4440819'],"['however, the addition of either u0126 or ly294002 together with tgf-beta1 severely induced apoptosis.']",1,0.1,40.0,1.0,40.1
17,apoptotic process,bioprocess,go:0006915,nan,nan,nan,nan,nan,ras,family,pf00071,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc4440819'],"['consequently, one aspect of the physiological significance of the tgf-beta1-activated ras -- erk pathway and pi3k -- akt signaling might be preventing apoptosis that can be induced by tgf-beta1.']",1,0.1,40.0,1.0,40.1
18,apoptotic process,bioprocess,go:0006915,nan,nan,nan,nan,nan,tgfb1,protein,p01137,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4440819'],"['consequently, one aspect of the physiological significance of the tgf-beta1-activated ras -- erk pathway and pi3k -- akt signaling might be preventing apoptosis that can be induced by tgf-beta1.']",1,0.1,40.0,1.0,40.1
19,apoptotic process,bioprocess,go:0006915,nan,nan,nan,nan,nan,u0126,simple-chemical,chebi:90693,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4440819'],"['however, the addition of either u0126 or ly294002 together with tgf-beta1 severely induced apoptosis.']",1,0.1,40.0,1.0,40.1
20,apoptotic process,bioprocess,go:0006915,nan,nan,nan,nan,nan,vegf,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc3809567'],"['several mechanisms that may account for the improved immune response have been described such as increased mda expression on melanoma cells and decreased intra-tumoral vegf production, others remain speculative, such as increased cross presentation t']",1,0.1,40.0,1.0,40.1
22,bcl2,protein,p10415,nan,nan,nan,nan,nan,akt inhibitors,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc4067595'],"['for meki, synergism has been demonstrated for pi3k and akt inhibitors, dexamethasone, nutlin-3a, which induces the mdm2-p53 axis, and the bcl-2 and bcl-x (l) inhibitor, navitoclax (abt263).']",1,0.1,40.0,1.0,40.1
50,endocytosis,bioprocess,go:0006897,nan,nan,nan,nan,nan,cell migration,bioprocess,go:0016477,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc4020307'],"['awd functions as a negative regulator of cell migration in tracheal and border cells by downregulating receptor levels on the cell surface through dynamin mediated endocytosis [xref_bibr, xref_bibr], thus it suppresses cell motility through receptor ']",1,0.1,40.0,1.0,40.1
52,epithelial to mesenchymal transition,bioprocess,go:0001837,nan,nan,nan,nan,nan,da-raf,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4440819'],"['although da-raf knockdown abrogated tgf-beta1-induced emt, the abrogation of emt was reversed by the addition of the mek inhibitor.']",1,0.1,40.0,1.0,40.1
58,epithelial to mesenchymal transition,bioprocess,go:0001837,nan,nan,nan,nan,nan,ras-erk,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc4440819'],"['here, we show that the ras-erk pathway negatively regulates tgf-beta1-induced emt in rle-6tn cells and that da-raf1 (da-raf), a splicing isoform of a-raf and a dominant negative antagonist of the ras-erk pathway, plays an essential role in emt.']",1,0.1,40.0,1.0,40.1
59,epithelial to mesenchymal transition,bioprocess,go:0001837,nan,nan,nan,nan,nan,smad,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4440819'],"['in contrast, the ras -- erk pathway interferes with tgf-beta1-induced, smad signaling mediated emt in primary cultured aecs and aec cell lines [xref_bibr, xref_bibr].']",1,0.1,40.0,1.0,40.1
102,ksr2,protein,q6vab6,nan,nan,nan,nan,nan,braf,protein,p15056,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4020307'],"['moreover, brennan and co-workers showed that b-raf dimerization with ksr2 could allosterically stimulate the kinase activity of ksr2 towards mek [xref_bibr], however it is not known yet whether this transactivation event is mediated by the nta of b-r']",1,0.1,40.0,1.0,40.1
104,mapk,bioprocess,d020928,nan,nan,nan,nan,nan,braf,protein,p15056,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc3809567'],['we recently explored a potential link between constitutive mapk pathway upregulation driven by a braf v600 mutation and dc function using a human melanoma-dc co-culture system.'],1,0.1,40.0,1.0,40.1
105,mapk,bioprocess,d020928,nan,nan,nan,nan,nan,braf inhibitors,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4179759'],"['although mapk pathway inhibitors such as braf inhibitors and mek inhibitors have demonstrated significant improvement of the clinical response rate, pfs, and os in comparison with chemotherapy in patients with advanced melanoma harboring braf mutatio']",1,0.1,40.0,1.0,40.1
106,mapk,bioprocess,d020928,nan,nan,nan,nan,nan,dendritic cells,bioprocess,d003713,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc3809567'],['we recently explored a potential link between constitutive mapk pathway upregulation driven by a braf v600 mutation and dc function using a human melanoma-dc co-culture system.'],1,0.1,40.0,1.0,40.1
107,mapk,bioprocess,d020928,nan,nan,nan,nan,nan,ec 2.7.12.2 (mitogen-activated protein kinase kinase) inhibitor,simple-chemical,chebi:88286,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4179759'],"['although mapk pathway inhibitors such as braf inhibitors and mek inhibitors have demonstrated significant improvement of the clinical response rate, pfs, and os in comparison with chemotherapy in patients with advanced melanoma harboring braf mutatio']",1,0.1,40.0,1.0,40.1
108,mapk,bioprocess,d020928,nan,nan,nan,nan,nan,gna11,protein,p29992,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4179759'],"['although uveal melanomas rarely have braf and nras mutations, the mapk pathway is constitutively activated by gnaq or gna11 mutations that occur in approximately 80% of primary uveal melanomas.']",1,0.1,40.0,1.0,40.1
109,mapk,bioprocess,d020928,nan,nan,nan,nan,nan,gnaq,protein,p50148,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4179759'],"['although uveal melanomas rarely have braf and nras mutations, the mapk pathway is constitutively activated by gnaq or gna11 mutations that occur in approximately 80% of primary uveal melanomas.']",1,0.1,40.0,1.0,40.1
111,mapk,bioprocess,d020928,nan,nan,nan,nan,nan,ksr1,protein,q8ivt5,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4020307'],"['these data suggest that mouse ksr1 is not strictly required for, but rather enhances mapk signaling.']",1,0.1,40.0,1.0,40.1
1,acta2,protein,p62736,nan,nan,nan,nan,nan,tgfb1,protein,p01137,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['increaseamount'],['pmc4440819'],"['on the other hand, the acta2 mrna level was increased by tgf-beta1 treatment, and introduction of either of the daraf sirnas abrogated this increase (xref_fig).']",1,0.1,40.0,1.0,40.1
113,mapk,bioprocess,d020928,nan,nan,nan,nan,nan,ras,family,pf00071,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc3843736'],['phosphorylation of stat3 on s727 in ras transformed mefs and its inhibition by treatment with mek inhibitors provided strong evidence for a role for ras activated mapk in stat3 s727 phosphorylation.'],1,0.1,40.0,1.0,40.1
114,mapk,bioprocess,d020928,nan,nan,nan,nan,nan,selumetinib,simple-chemical,chebi:90227,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc4179759'],"['xref_bibr - xref_bibr therefore, mapk pathway inhibition by selumetinib was evaluated in other malignancies, including colorectal, pancreatic, non-small-cell lung, and hepatocellular cancer, as well as melanoma.']",1,0.1,40.0,1.0,40.1
115,mapk-luciferase reporter,nan,nan,nan,nan,nan,nan,nan,rasip1,protein,q5u651,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc3498325'],"['as shown in xref_fig, transient transfection of a rasip1 expression vector increased mapk-luciferase reporter activity dose-dependently, particularly in the presence of bfgf.']",1,0.1,40.0,1.0,40.1
116,mapk1,protein,p28482,nan,nan,nan,nan,nan,mir335,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['increaseamount'],['pmc4067595'],"['one possible mechanism is the deregulated expression of a microrna, mir335 that targets and regulates levels of erk2.']",1,0.1,40.0,1.0,40.1
117,mark2,protein,q7kzi7,nan,nan,nan,nan,nan,ksr1,protein,q8ivt5,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['phosphorylation'],['pmc4020307'],['nan'],1,0.1,40.0,1.0,40.1
118,mdm2-p53 axis,nan,nan,nan,nan,nan,nan,nan,akt inhibitors,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc4067595'],"['for meki, synergism has been demonstrated for pi3k and akt inhibitors, dexamethasone, nutlin-3a, which induces the mdm2-p53 axis, and the bcl-2 and bcl-x (l) inhibitor, navitoclax (abt263).']",1,0.1,40.0,1.0,40.1
119,mdm2-p53 axis,nan,nan,nan,nan,nan,nan,nan,dexamethasone,simple-chemical,chebi:41879,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc4067595'],"['for meki, synergism has been demonstrated for pi3k and akt inhibitors, dexamethasone, nutlin-3a, which induces the mdm2-p53 axis, and the bcl-2 and bcl-x (l) inhibitor, navitoclax (abt263).']",1,0.1,40.0,1.0,40.1
120,mdm2-p53 axis,nan,nan,nan,nan,nan,nan,nan,pi3k,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc4067595'],"['for meki, synergism has been demonstrated for pi3k and akt inhibitors, dexamethasone, nutlin-3a, which induces the mdm2-p53 axis, and the bcl-2 and bcl-x (l) inhibitor, navitoclax (abt263).']",1,0.1,40.0,1.0,40.1
121,mef2,nan,nan,nan,nan,nan,nan,nan,ras-erk,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc2064279'],['the ras-erk pathway negatively regulates skeletal muscle cell differentiation by suppressing the expression or functions of the muscle specific transcription factors myod and mef2.'],1,0.1,40.0,1.0,40.1
129,mek-erk,nan,nan,nan,nan,nan,nan,nan,araf,protein,p10398,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc2064279'],"['because da-raf1 seems to negatively regulate the b-raf- mek-erk pathway during c2c12 cell differentiation, it may be involved in the induction of differentiation.']",1,0.1,40.0,1.0,40.1
101,ksr,nan,nan,nan,nan,nan,nan,nan,ras,family,pf00071,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4020307'],"['thus, upon ras activation ksr brings mek to the plasma membrane in close proximity to the raf kinase.']",1,0.1,40.0,1.0,40.1
100,ksr,nan,nan,nan,nan,nan,nan,nan,proteasome,bioprocess,go:0000502,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc4020307'],"['hsp90 is a binding partner of ksr, which might promote the proteasome mediated degradation of ksr, thus attenuating erk signaling.']",1,0.1,40.0,1.0,40.1
99,kras,protein,p01116,nan,nan,nan,nan,nan,stat3,protein,p40763,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['phosphorylation'],['pmc3843736'],['nan'],1,0.1,40.0,1.0,40.1
88,gnaq,protein,p50148,nan,nan,nan,nan,nan,selumetinib,simple-chemical,chebi:90227,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4179759'],"['xref_bibr, xref_bibr another preclinical study demonstrated that the combination of selumetinib and a mammalian target of rapamycin (mtor) inhibitor (azd8055) which is downstream of pi3k and akt pathway, induces tumor regression in braf mutant uveal ']",1,0.1,40.0,1.0,40.1
60,epithelial to mesenchymal transition,bioprocess,go:0001837,nan,nan,nan,nan,nan,smad2_3,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4440819'],"['consequently, activated erk interferes with smad2/3 function that induces emt.']",1,0.1,40.0,1.0,40.1
61,epithelial to mesenchymal transition,bioprocess,go:0001837,nan,nan,nan,nan,nan,sprouty,family,pf05210,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc4440819'],"['conversely, overexpression of sprouty in lens epithelial cells suppresses tgf-beta-induced signaling and emt.']",1,0.1,40.0,1.0,40.1
82,expression,nan,nan,nan,nan,nan,nan,nan,fgf2,protein,p09038,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc4440819'],"['fgf2 inhibited the tgf- β 1-induced αsma expression in a dose-dependent manner, i.e., 10 ng/ml fgf2 did not suppress the αsma expression, but 50 ng/ml fgf2 reduced the expression to the basal level, and 100 ng/ml fgf2 further reduced the expression (']",1,0.1,40.0,1.0,40.1
83,extracellular-regulated kinase,nan,nan,nan,nan,nan,nan,nan,ras,family,pf00071,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc2064279'],"['the binding of active ras to raf triggers activation of the extracellular regulated kinase (erk)-mapk pathway (raf-mapk and erk kinase [mek]-erk), which participates in a variety of cellular, physiological, and pathological responses.']",1,0.1,40.0,1.0,40.1
84,fgf2,protein,p09038,nan,nan,nan,nan,nan,ec 2.7.1.127 (inositol-trisphosphate 3-kinase) inhibitor,simple-chemical,chebi:84801,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4440819'],"['although the ras -- erk pathway negatively regulates emt in rle cells, pi3k -- akt signaling may not affect emt, because the pi3k inhibitor ly294002 did not reverse the fgf2 induced prevention of emt.']",1,0.1,40.0,1.0,40.1
85,fgf2,protein,p09038,nan,nan,nan,nan,nan,ly294002,simple-chemical,chebi:65329,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc4440819'],"['although the ras -- erk pathway negatively regulates emt in rle cells, pi3k -- akt signaling may not affect emt, because the pi3k inhibitor ly294002 did not reverse the fgf2 induced prevention of emt.']",1,0.1,40.0,1.0,40.1
86,firefly luciferase,nan,nan,nan,nan,nan,nan,nan,vemurafenib,simple-chemical,chebi:63637,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc3809567'],"['in this study, no difference in frequencies of adoptively transferred t cells was observed in tumors, lymph nodes, or spleen as assessed ex vivo by flow cytometry and immunofluorescence imaging and in vivo by tracking of the firefly luciferase transg']",1,0.1,40.0,1.0,40.1
97,kras,protein,p01116,nan,nan,nan,nan,nan,egfr,protein,p00533,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc2911390'],"['as such, there has been no clear relationship between kras mutation status and clinical outcomes in patients treated with the egfr tyrosine kinase inhibitors gefitinib or erlotinib [xref_bibr].']",1,0.1,40.0,1.0,40.1
87,gnaq,protein,p50148,nan,nan,nan,nan,nan,mtor,protein,p42345,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc4179759'],"['xref_bibr, xref_bibr another preclinical study demonstrated that the combination of selumetinib and a mammalian target of rapamycin (mtor) inhibitor (azd8055) which is downstream of pi3k and akt pathway, induces tumor regression in braf mutant uveal ']",1,0.1,40.0,1.0,40.1
89,gtp,simple-chemical,chebi:15996,nan,nan,nan,nan,nan,gef,bioprocess,go:0008433,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4067595'],"['ras activation is catalyzed by guanine nucleotide exchange factors (gefs), such as son of sevenless (sos), which displace gdp and allow gtp to preferentially occupy the vacant nucleotide binding site due to its relative abundance in the cytoplasm.']",1,0.1,40.0,1.0,40.1
90,gtp,simple-chemical,chebi:15996,nan,nan,nan,nan,nan,guanine,simple-chemical,chebi:16235,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4067595'],"['ras activation is catalyzed by guanine nucleotide exchange factors (gefs), such as son of sevenless (sos), which displace gdp and allow gtp to preferentially occupy the vacant nucleotide binding site due to its relative abundance in the cytoplasm.']",1,0.1,40.0,1.0,40.1
91,"h-, k-,",nan,nan,nan,nan,nan,nan,nan,gef,bioprocess,go:0008433,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4440819'],"['the rtk mediated activation of a specific gef activates the small gtpase ras (h-, k-, and n-ras) via gtp loading.']",1,0.1,40.0,1.0,40.1
92,"h-, n-",nan,nan,nan,nan,nan,nan,nan,stat3,protein,p40763,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['phosphorylation'],['pmc3843736'],['nan'],1,0.1,40.0,1.0,40.1
93,h-rasv12,nan,nan,nan,nan,nan,nan,nan,mek-erk,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc3843736'],"['if stat3 s727 phosphorylation is a critical mek-erk target, then inhibition of this pathway in h-rasv12 transformed cells should impede colony formation.']",1,0.1,40.0,1.0,40.1
94,hras,protein,p01112,nan,nan,nan,nan,nan,stat3,protein,p40763,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['phosphorylation'],['pmc3843736'],['nan'],1,0.1,40.0,1.0,40.1
95,ifng,protein,p01579,nan,nan,nan,nan,nan,vemurafenib,simple-chemical,chebi:63637,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc3809567'],"['however, adoptively transferred t cells exhibited increased functionality as measured by ifn-gamma production and their ability to lyse tumor cells in mice treated with act and vemurafenib.']",1,0.1,40.0,1.0,40.1
96,ipf,nan,nan,nan,nan,nan,nan,nan,tgfb1,protein,p01137,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4440819'],['these studies use human cells and tissues from ipf patient lungs; rodent lung models treated with bleomycin or transforming growth factor-beta1 (tgf-beta1); and rodent primary cultured aec2s or rat aec2 cell line rle-6tn (rle) cells treated with tgf-'],1,0.1,40.0,1.0,40.1
112,mapk,bioprocess,d020928,nan,nan,nan,nan,nan,nme1,protein,p15531,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['inhibition'],['pmc4020307'],"['overexpression of nm23-h1 in mda-mb-435 breast carcinoma cells resulted in decreased activated mapk (pmapk) levels without affecting the level of total mapk, suggesting that nm23-h1 inhibits ras and mapk signaling through ksr phosphorylation and inac']",1,0.1,40.0,1.0,40.1
126,mek,nan,nan,nan,nan,nan,nan,nan,raf,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,"['nan', 'nan', 'nan']","['activation', 'inhibition', 'inhibition']","['pmc4067595', 'pmc4440819', 'pmc4440819']","['raf subsequently activates mek1/2, which display restricted substrate specificity for erk1/2.', 'both sprouty and rkip bind to raf to inhibit the erk pathway by preventing the binding of mek.', 'both sprouty and rkip bind to raf to inhibit the erk pathway by preventing the binding of mek.']",3,10.0,1.0,1.0,31.0
70,erk,bioprocess,d020928,nan,nan,nan,nan,nan,mek,nan,nan,nan,nan,nan,nan,nan,nan,nan,i,['nan'],['activation'],['pmc4440819'],"['in contrast, fgf2 stimulation or overexpression of constitutively active ras, raf, or mek enhances the activity of the tgf-beta1-induced ras -- erk pathway.']",1,10.0,1.0,1.0,11.0
